Nuvalent Insider Sold Shares Worth $403,621, According to a Recent SEC Filing
Emily Conley, Director, on July 15, 2024, sold 5,000 shares in Nuvalent (NUVL) for $403,621. Following the Form 4 filing with the SEC, Conley has control over a total of 2,507 shares of the company,
Express News | Nuvalent To Present Updated Data From ARROS-1 Phase 1/2 Clinical Trial Of Zidesamtinib And ALKOVE-1 Phase 1/2 Clinical Trial Of NVL-655 at ESMO Congress 2024
Express News | Nuvalent Announces Promotion of Henry Pelish, Ph.d. to Chief Scientific Officer
Nuvalent(NUVL.US) Officer Sells US$219.69K in Common Stock
$Nuvalent(NUVL.US)$ Officer Miller Deborah Ann sold 3,000 shares of common stock on Jul 8, 2024 at an average price of $73.23 for a total value of $219.69K.Source: Announcement What is statement of
Nuvalent Is Maintained at Buy by Stifel
Nuvalent Is Maintained at Buy by
Stifel Maintains Nuvalent(NUVL.US) With Buy Rating, Raises Target Price to $115
Stifel analyst Bradley Canino maintains $Nuvalent(NUVL.US)$ with a buy rating, and adjusts the target price from $103 to $115.According to TipRanks data, the analyst has a success rate of 46.4% and
Express News | Nuvalent Inc : Stifel Raises Target Price to $115 From $103
Nuvalent(NUVL.US) Officer Sells US$377.7K in Common Stock
$Nuvalent(NUVL.US)$ Officer Noci Darlene sold 5,000 shares of common stock on Jul 1, 2024 at an average price of $75.54 for a total value of $377.7K.Source: Announcement What is statement of changes i
Nuvalent(NUVL.US) Officer Sells US$754.34K in Common Stock
$Nuvalent(NUVL.US)$ Officer Balcom Alexandra sold 10,000 shares of common stock on Jun 28, 2024 at an average price of $75.43 for a total value of $754.34K.Source: Announcement What is statement of ch
Nuvalent(NUVL.US) Director Sells US$160.44K in Common Stock
$Nuvalent(NUVL.US)$ Director Shair Matthew sold 2,000 shares of common stock on Jun 24, 2024 at an average price of $80.22 for a total value of $160.44K.Source: Announcement What is statement of chang
Nuvalent(NUVL.US) Director Sells US$387.78K in Common Stock
$Nuvalent(NUVL.US)$ Director Conley Emily sold 5,000 shares of common stock on Jun 14, 2024 at an average price of $77.56 for a total value of $387.78K.Source: Announcement What is statement of change
Novavax And Agios Pharmaceuticals Were Among The 10 Biggest Mid-Cap Gainers Last Week (June 1-June 7): Are These In Your Portfolio?
These mid-cap stocks were the best performers in the last week. Are they in your portfolio?Agios Pharmaceuticals Inc (NASDAQ:AGIO) shares soared 29.13% in the last week after reporting that its transf
Nuvalent(NUVL.US) Officer Sells US$643.21K in Common Stock
$Nuvalent(NUVL.US)$ Officer Miller Deborah Ann sold 8,000 shares of common stock on Jun 6, 2024 at an average price of $80.4 for a total value of $643.21K.Source: Announcement What is statement of cha
Nuvalent Insider Sold Shares Worth $643,213, According to a Recent SEC Filing
Deborah Ann Miller, Chief Legal Officer, on June 06, 2024, sold 8,000 shares in Nuvalent (NUVL) for $643,213. Following the Form 4 filing with the SEC, Miller has control over a total of 33,300 shares
Nuvalent(NUVL.US) Director Sells US$134.44K in Common Stock
$Nuvalent(NUVL.US)$ Director Shair Matthew sold 2,000 shares of common stock on May 28, 2024 at an average price of $67.22 for a total value of $134.44K.Source: Announcement What is statement of chang
Nuvalent to Participate in the 2024 Jefferies Global Healthcare Conference
Nuvalent, Inc. (Nasdaq: NUVL), a clinical-stage biopharmaceutical company focused on creating precisely targeted therapies for clinically proven...
Nuvalent(NUVL.US) Director Sells US$345.45K in Common Stock
$Nuvalent(NUVL.US)$ Director Conley Emily sold 5,000 shares of common stock on May 15, 2024 at an average price of $69.09 for a total value of $345.45K.Source: Announcement What is statement of change
Nuvalent Insider Sold Shares Worth $345,450, According to a Recent SEC Filing
Emily Conley, Director, on May 15, 2024, sold 5,000 shares in Nuvalent (NUVL) for $345,450. Following the Form 4 filing with the SEC, Conley has control over a total of 8 shares of the company, with 8
Express News | Wedbush Reiterates Outperform on Nuvalent, Maintains $99 Price Target
Nuvalent Analyst Ratings
Date Upside/Downside Analyst Firm Price Target Change Rating Change Previous / Current Rating 05/17/2024 32.85% Wedbush → $99 Reiterates Outperform → Outperform 04/17/2024 30.17% Jefferies → $97 Initi